Mohamed Ahmed | Quality- medicine | Best Research Article Award

Posted on by ScienceFather

Assist Prof Dr. Mohamed Ahmed | Quality- medicine | Best Research Article Award

Chair of qualit unit, College of engineering- KSU, Saudi Arabia

Dr. Mohamed Abdel Fattah Ahmed – Short Biography
🧑‍🏫 Dr. Mohamed Abdel Fattah Ahmed is a dedicated academic professional with an extensive career in engineering education. He currently serves as an Assistant Professor at King Saud University, College of Engineering, in Riyadh, Saudi Arabia, a position he has held since 1993. His earlier academic roles include teaching at Assiut University, Egypt, and part-time at Banah Higher Technological Institute. With over four decades of experience, Dr. Ahmed has made significant contributions to industrial engineering and mechanical engineering, specializing in quality management, decision-making, and project management. His broad expertise encompasses cost estimation, workshop design, and spare parts control.

Profile

Scopus

Strengths for the Award

Dr. Mohamed Abdel Fattah Ahmed demonstrates a robust academic and research background with a significant focus on engineering fields, particularly industrial and mechanical engineering. His extensive education, including a Ph.D. in Industrial Engineering from Japan, along with practical training in Total Quality Management (TQM), highlights his technical proficiency. The most notable strength is his recent contributions to the journal Mechanics of Advanced Materials and Structures in 2023. His research topics, including nonlinear continuum thermo-mechanics, advanced building materials, and artificial intelligence applications in engineering, show innovation, relevance, and interdisciplinary scope. These subjects are highly applicable to modern challenges in materials science, engineering, and artificial intelligence, marking his work as impactful and forward-thinking.

Areas for Improvement

While Dr. Mohamed’s research addresses contemporary issues, the language barrier might pose challenges, especially when writing and communicating complex ideas in English. His proficiency is described as “fair enough,” which may limit the clarity and accessibility of his publications. Additionally, while his research shows a high degree of specialization, expanding the practical applications of his findings or engaging in more collaborative, international research efforts could elevate his work’s influence and reach. Moreover, enhancing the focus on direct real-world implications, such as environmental or societal benefits, would strengthen the potential for wider recognition and impact in multidisciplinary contexts.

Education

🎓 Dr. Ahmed holds a Ph.D. in Industrial Engineering from Chubu University, Japan (1989), where he focused on quality engineering and service parts control. He also earned an M.Sc. in Mechanical Engineering from Assiut University, Egypt (1982), and a B.Sc. in Production Engineering from Alexandria University, Egypt (1976). Additionally, he holds a Diploma in Total Quality Management (TQM) from Kyoto University, Japan (1985). His further qualifications include certified Six Sigma Master Black Belt and PMP certification from PMI-USA.

Experience

🔧 Throughout his career, Dr. Ahmed has held various academic and professional positions, starting as a Teaching Assistant at Assiut University (1978-1983) and later as an Assistant Professor at the same institution (1990-1993). His long-standing tenure at King Saud University has allowed him to impart knowledge in industrial and production engineering, and he has been actively involved in various administrative and research roles. He is also an accredited Quality Management System Auditor (ISO 9001:2015).

Research Interests

🧠 Dr. Ahmed’s research interests span across several domains, including engineering management education, cost estimation, academic accreditation, decision-making processes, and quality management. He is particularly passionate about project management, workshop design, and spare parts control. His research contributes significantly to improving management systems and industrial processes.

Awards

🏆 Dr. Ahmed has received several certifications and professional recognitions, including being a Six Sigma Certified Master Black Belt (Integral-USA) and an IRCA Certified Quality Management System Auditor (ISO 9001:2015). His contributions to the academic and professional fields of engineering management have earned him respect and accolades throughout his career.

Publications Top Notes

📚 Dr. Ahmed has an impressive list of research publications, contributing to significant advancements in engineering and applied sciences. Below are some of his recent works:

“Robust Framework for Severity Detection of Knee Osteoarthritis Using an Efficient Deep Learning Model”, International Journal of Pattern Recognition and Artificial Intelligence, 2023. DOI: 10.1142/S0218001423520109

“Multi-Agent Variational Approach for Robotics: A Bio-Inspired Perspective”, Biomimetics, 2023. DOI: 10.3390/biomimetics8030294

“A Novel Evolving Framework for Energy Management in Combined Heat and Electricity Systems with Demand Response Programs”, Sustainability, 2023. DOI: 10.3390/su151310481

“Forced Vibration Analysis of the Axially Reinforced Thick Concrete Plate Using General Expression of the Polynomial Series Theory: Development and Validation of a Deep Neural Network”, Materials Today Communications, 2023. DOI: 10.1016/j.mtcomm.2023.106419

“Nonlinear Continuum Thermo-Mechanics of the Composite Thick Panel Used in Concrete Ceilings via General Expression of the Polynomial Series Theory”, Mechanics of Advanced Materials and Structures, 2023. DOI: 10.1080/15376494.2023.2218367

“Soft Computational Approach on the Thermoelastic Assessment of Sandwich Beams with Transversely Functionally Graded Composite Concrete Face-Sheets as an Advanced Building Material”, Mechanics of Advanced Materials and Structures, 2023. DOI: 10.1080/15376494.2023.2227413

Conclusion

Dr. Mohamed Abdel Fattah Ahmed is a strong candidate for the “Best Research Article Award” due to his substantial contributions to engineering and materials science. His innovative research in advanced materials, thermo-mechanics, and the integration of artificial intelligence aligns well with current global trends. However, improvement in communication skills and broader collaboration would further enhance the recognition of his work. Overall, his depth of knowledge and recent impactful publications make him a compelling contender for the award.

Yan Ni | Pharmaceutical Research | Best Researcher Award

Posted on by ScienceFather

Dr. Yan Ni | Pharmaceutical Research | Best Researcher Award

Executive Director, Passage bio, United States

Profile

Google Scholar

Researcher Evaluation for “Best Researcher Award”

Strengths for the Award:

Extensive Expertise in Drug Development: Yan G. Ni, PhD, has over 15 years of experience in drug development, particularly in small molecules, biologics, and gene therapies. His work spans several critical therapeutic areas, including neurological and cardiovascular diseases, immune-oncology, hematology, and rare diseases. His contributions to IND/CTA submissions and regulatory interactions further highlight his deep involvement in the field.

Leadership in Translational Biomarker and Precision Medicine: Dr. Ni has demonstrated significant expertise in integrating preclinical and clinical biomarker strategies, contributing to the successful design and execution of biomarker-based clinical endpoints. His role in implementing PK and immunogenicity strategies across different phases of studies showcases his ability to bridge the gap between research and clinical application, a crucial factor in modern drug development.

Proven Management Skills: Dr. Ni’s management experience is evident in his ability to build and lead high-performing cross-functional teams. His leadership roles in international professional organizations like the AAPS and SAPA, as well as his track record of mentoring and inspiring others, underline his effectiveness as a leader in both scientific and organizational contexts.

High Scientific Productivity: With over 35 peer-reviewed publications, several book chapters, and six U.S. patents, Dr. Ni’s scientific output is substantial. His contributions to industry white papers and his role as an organizer and invited speaker at national and international conferences further affirm his thought leadership in the field.

Recognition and Awards: Dr. Ni has received numerous prestigious awards, such as the Passage Bio High Impact Award, Regeneron High Impact Award, AAPS Excellence in Ligand Binding Assays Award, and Merck Award of Excellence. These accolades reflect his high-impact contributions to the field and recognition by peers and industry leaders.

Areas for Improvement:

Broader Impact Beyond Specialized Fields: While Dr. Ni’s expertise is well-recognized within specialized areas such as biomarkers, precision medicine, and drug development, expanding his influence into broader, interdisciplinary research domains could enhance his candidacy for a “Best Researcher Award.” For example, engaging in research that impacts public health or other critical global issues might increase his visibility and impact.

Further Innovation in Emerging Therapeutic Areas: While Dr. Ni has made significant contributions to established therapeutic areas, greater involvement in cutting-edge fields such as artificial intelligence in drug discovery or personalized medicine could position him as a pioneer in these rapidly evolving areas.

Enhanced Collaboration with Global Initiatives: Although Dr. Ni has demonstrated leadership in professional organizations and consortia, expanding his collaborative efforts to include global health initiatives or large-scale, multi-national research projects could further amplify his contributions and align with broader global research priorities.

Professional Experience

Passage Bio, Philadelphia, PA
Executive Director, Biomarkers and Precision Medicine
2021-Present
Senior Director, Head of Biomarkers and Precision Medicine
2020-2021

Built and led a high-performing team responsible for driving clinical biomarker, PK/biodistribution, immunogenicity studies, and supporting clinical operations.

Developed and implemented biomarker, PK, and immunogenicity strategies to inform decision-making for neurodegenerative disease portfolios.

Led biomarker and precision medicine support for IND/CTA submissions and global regulatory interactions.

Oversaw partnerships with external CROs and laboratories, and collaborated with Clinical Study Teams on biomarker inclusion in clinical portfolios.

Regeneron, Tarrytown, NY
Associate Director, Precision Medicine, Early Clinical Development & Experimental Sciences
2016-2020

Designed and implemented biomarker strategies to support dose selection and efficacy readings for complement-mediated rare diseases.

Provided strategic leadership for discovery and early cardiovascular programs, influencing biomarker-driven decisions on target validation, disease indication selection, and patient stratification.

Led multiple biomarker-focused natural history studies with academic and clinical centers.

Bristol Myers Squibb, Princeton, NJ
Senior Research Investigator II, R&D/PD/ABD/BAS-Biologics
2012-2016

Supported biomarker bioanalytical strategy implementation for immuno-oncology, immunology, and cardiovascular diseases.

Supervised biomarker method development and validation by internal staff and CROs.

Provided strategic and technical input on biomarker bioanalytical plans, resources, and timelines for FIH and PoC studies.

Merck & Co., Inc., Rahway, NJ
Senior Research Scientist, Cardiovascular Franchise Atherosclerosis Group
2007-2011

Led the development of a 2nd generation fully human monoclonal antibody for PCSK9.

Established ELISA-based pharmacodynamics and target engagement biomarker assays.

University of Texas Southwestern Medical Center, Dallas, TX
Research Assistant Professor, Internal Medicine Department, Cardiology
2001-2007
Research Scientist, Department of Pharmacology & Alliance for Cellular Signaling
2001-2007

Conducted research on cardiac hypertrophy, heart failure, and aging, focusing on Akt and FOXO transcriptional factors.

Education and Training

Persuasive Leadership Development: Wharton Business School, University of Pennsylvania

Postdoctoral Training: Yale University, under Professors Gary Rudnick and Eric Nestler

Ph.D. in Neuroscience: University of California, Irvine, under Professor Ricardo Miledi

M.S. in Pharmacology: Institute of Basic Medical Sciences, Beijing, China

B.S. in Biochemistry: Anhui University, Hefei, China

Professional Honors

Passage Bio High Impact Award (2021)

Regeneron High Impact Award and Multiple STAR Awards (2016-2020)

AAPS Excellence in Ligand Binding Assays Award (2015)

BMS R&D ROC Award and Multiple STAR Awards (2014)

Merck Award of Excellence (2007, 2008, 2009)

Professional Affiliations

American Association of Pharmaceutical Scientists (AAPS):

Founding Member and Chair of the Biomarkers and Translational Medicine Community

Founding Member and Chair of the Gene and Cell Therapeutic Products Community

Sino-American Pharmaceutical Professionals Association (SAPA):

Director for Public Outreach and Executive Committee Member

Publications

Yang, J., Mapelli, C., Wang, Z., et al. (2022). An Optimized Agonist Peptide of Protease-activated Receptor 4 and its Use in a Platelet Aggregation Assay to Monitor the Pharmacodynamic Effects of PAR4 Antagonists. Platelets. DOI: 10.1080/09537104.2022.2053091

Hays, A., Amaravadi, L., Fernandez-Metzler, C., et al. (2022). Is Incurred Sample Reanalysis (ISR) applicable in Biomarker Assays? AAPS J, 24:65. DOI: 10.1208/s12248-022-00708-y

Ni, Y.G., King, L., Fernández-Metzler, C. (2022). Recent Progress in Biomarker Bioanalysis and Target Engagement in Bioanalytical Aspects in Biological Therapeutics. ISBN: 9781119523215. Edited by Xu, X. & Xu, W.

Conclusion:

Dr. Yan G. Ni, PhD, is an outstanding candidate for the “Best Researcher Award” based on his extensive contributions to drug development, biomarker research, and precision medicine. His leadership, scientific productivity, and recognition by peers make him a strong contender for the award. However, expanding his research impact into broader and more emerging fields could further strengthen his profile for this prestigious recognition.